Unexplained Early Neurological Deterioration After Intravenous Thrombolysis Incidence, Predictors, and Associated Factors

被引:115
|
作者
Seners, Pierre [1 ,2 ]
Turc, Guillaume [1 ,2 ]
Tisserand, Marie [1 ,3 ]
Legrand, Laurence [1 ,3 ]
Labeyrie, Marc-Antoine [1 ,3 ]
Calvet, David [1 ,2 ]
Meder, Jean-Francois [1 ,3 ]
Mas, Jean-Louis [1 ,2 ]
Oppenheim, Catherine [1 ,3 ]
Baron, Jean-Claude [1 ,2 ]
机构
[1] Univ Paris 05, Sorbonne Paris Cite, INSERM, UMR S894, Paris, France
[2] Ctr Hosp St Anne, Serv Neurol, Paris, France
[3] Ctr Hosp St Anne, Serv Neuroradiol, Paris, France
关键词
stroke; thrombolytic therapy; ACUTE ISCHEMIC-STROKE; CLINICAL DETERIORATION; ATRIAL-FIBRILLATION; HYPERGLYCEMIA; IMPROVEMENT; MANAGEMENT; INFARCTION; TISSUE; TRIAL; PA;
D O I
10.1161/STROKEAHA.114.005426
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Early neurological deterioration (END) after anterior circulation stroke is a serious clinical event strongly associated with poor outcome. Regarding specifically END occurring within 24 hours of intravenous recombinant tissue-type plasminogen activator, apart from definite causes such as symptomatic intracranial hemorrhage and malignant edema whose incidence, predictors, and clinical management are well established, little is known about END without clear mechanism (ENDunexplained). Methods-We analyzed 309 consecutive patients thrombolysed intravenously <= 4.5 hours from onset of anterior circulation stroke. ENDunexplained was defined as a >= 4-point deterioration on 24-hour National Institutes of Health Stroke Scale, without definite mechanism on concomitant imaging. ENDunexplained and no-END patients were compared for pretreatment clinical and imaging (including magnetic resonance diffusion and diffusion/perfusion mismatch volumes) data and 24-hour post-treatment clinical (including blood pressure and glycemic changes) and imaging (24-hour recanalization) data, using univariate logistic regression. Exploratory multivariate analysis was also performed after variable reduction, with bootstrap analysis for internal validation. Results-Among 33 END patients, 23 (7% of whole sample) had ENDunexplained. ENDunexplained was associated with poor 3-month outcome (P<0.01). In univariate analysis, admission predictors of ENDunexplained included no prior use of antiplatelets (P=0.02), lower National Institutes of Health Stroke Scale score (P<0.01), higher glycemia (P=0.03), larger mismatch volume (P=0.03), and proximal occlusion (P=0.01), with consistent results from the multivariate analysis. Among factors recorded during the first 24 hours, only no recanalization was associated with END unexplained in multivariate analysis (P=0.02). Conclusions-ENDunexplained affected 7% of patients and accounted for most cases of END. Several predictors and associated factors were identified, with important implications regarding underlying mechanisms and potential prevention of this ominous event.
引用
收藏
页码:2004 / 2009
页数:6
相关论文
共 50 条
  • [21] Early Neurological Deterioration After Intravenous Thrombolysis Still No End in Sight in the Quest for Understanding END
    Mitsias, Panayiotis D.
    STROKE, 2020, 51 (09) : 2615 - 2617
  • [22] A novel nomogram predicting early neurological deterioration after intravenous thrombolysis for acute ischemic stroke
    Luo, Bang
    Yuan, Mei
    Kuang, Wending
    Wang, Yuzheng
    Chen, Liucui
    Zhang, Yang
    Chen, Gang
    HELIYON, 2024, 10 (01)
  • [23] Early neurological deterioration after intravenous thrombolysis of anterior vs posterior circulation stroke: a secondary analysis of INTRECIS
    Cui, Yu
    Meng, Wei-Hong
    Chen, Hui-Sheng
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Incidence and mechanism of early neurological deterioration after endovascular thrombectomy
    Kim, Jeong-Min
    Bae, Jae-Han
    Park, Kwang-Yeol
    Lee, Woong Jae
    Byun, Jun Soo
    Ahn, Suk-Won
    Shin, Hae-Won
    Han, Su-Hyun
    Yoo, Il-Han
    JOURNAL OF NEUROLOGY, 2019, 266 (03) : 609 - 615
  • [25] Causes, Predictors, and Timing of Early Neurological Deterioration and Symptomatic Intracranial Hemorrhage After Administration of IV tPA
    Shah, Kavit
    Clark, Alexander
    Desai, Shashvat M.
    Jadhav, Ashutosh P.
    NEUROCRITICAL CARE, 2022, 36 (01) : 123 - 129
  • [26] Analysis of Clinical Characteristics and Influencing Factors of Early Neurological Deterioration in Patients With Mild Stroke by Intravenous Alteplase Therapy
    Mao, Xin-Lei
    He, Si-Si
    Lin, Cai-Dan
    Huang, Xiang-Dong
    Sun, Jun
    NEUROLOGIST, 2024, 29 (05) : 275 - 279
  • [27] Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis
    Wu, Chuanjie
    Sun, Chenghe
    Wang, Lijun
    Lian, Yajun
    Xie, Nanchang
    Huang, Shengming
    Zhao, Wenbo
    Ren, Ming
    Wu, Di
    Ding, Jianping
    Song, Haiqing
    Wang, Yuping
    Ma, Qingfeng
    Ji, Xunming
    STROKE, 2019, 50 (12) : 3481 - 3487
  • [28] Revisiting 'progressive stroke': incidence, predictors, pathophysiology, and management of unexplained early neurological deterioration following acute ischemic stroke
    Seners, Pierre
    Baron, Jean-Claude
    JOURNAL OF NEUROLOGY, 2018, 265 (01) : 216 - 225
  • [29] Unexplained early neurological deterioration after endovascular treatment for acute large vessel occlusion: incidence, predictors, and clinical impact: Data from ANGEL-ACT registry
    Sun, Dapeng
    Tong, Xu
    Huo, Xiaochuan
    Jia, Baixue
    Raynald
    Wang, Anxin
    Ma, Gaoting
    Ma, Ning
    Gao, Feng
    Mo, Dapeng
    Song, Ligang
    Sun, Xuan
    Liu, Lian
    Deng, Yiming
    Li, Xiaoqing
    Wang, Bo
    Luo, Gang
    Wang, Yongjun
    Miao, Zhongrong
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2022, 14 (09) : 875 - +
  • [30] Incidence and predictors of intracranial hemorrhage after intravenous thrombolysis with tenecteplase
    Marnat, Gaultier
    Gerschenfeld, Gaspard
    Olindo, Stephane
    Sibon, Igor
    Seners, Pierre
    Clarencon, Frederic
    Smadja, Didier
    Chausson, Nicolas
    Ben Hassen, Wagih
    Piotin, Michel
    Caroff, Jildaz
    Alamowitch, Sonia
    Turc, Guillaume
    EUROPEAN STROKE JOURNAL, 2024, 9 (04) : 918 - 926